+462.0%
MRNA vs EPAM
-29.6%
+491.6%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | EPAM | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.7% | -0.1% | +0.9% | +0.8% |
| 7D | -8.2% | -4.5% | -3.8% | -5.5% |
| 30D | +125.6% | +14.6% | +110.9% | +112.7% |
| 3M | +197.1% | +23.1% | +174.0% | +175.4% |
| 6M | +148.5% | -19.5% | +167.9% | +147.6% |
| YTD | +363.3% | -44.1% | +407.4% | +407.5% |
| 1Y | +462.0% | -25.2% | +487.2% | +483.2% |
| All | +462.0% | -29.6% | +491.6% | +483.2% |
Cumulative growth
Daily Returns
Daily percentage return beside EPAM.
Daily Out/Under-Performance
Portfolio return minus EPAM return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EPAM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded EPAM wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling